Cat. No. Name Size Price Add Cart
KI1181TMC 12510 mg$426
TMC 12550 mg$704
TMC 1251 g$2132

Chemical Characteristic

Product NameTMC 125
SynonymsEtravirine, Intelence, R165335
CAS No.269055-15-4
Molecular Weight 435.28
FormulaC20H15BrN6O
Chemical Name4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile
SmilesC(#N)c1cc(c(c(c1)C)Oc1nc(nc(c1Br)N)Nc1ccc(cc1)C#N)C
Chemical Structure

Biological activities

TMC 125 is a nonnucleoside reverse transcriptase (NNRT) inhibitor. TMC 125 is identified as a next-generation NNRT inhibitor. TMC 125 significantly decreases the HIV viral load.[1] TMC 125 has high activity against wild-type and NNRTI-resistant HIV-1. TMC 125 markedly decreases HIV-1-RNA levels. [2] The IC50 of TMC 125 is 38 nM against reverse transcriptase. The EC50 of TMC 125 is ranging from 1.4 to 4.8 nM against HIV-1. In contrast, TMC 125 inhibits HIV-2 with an EC50 of 3.5 µM.[3] TMC 125 alone significantly decreases exposures of dolutegravir by ca. 70% for AUC0-T and by ca. 90% for CT.[4] TMC 125 significantly increases S-warfarin systemic clearance.[5] TMC 125 is mainly catalyzed by CYPs 3A4, 2C9, and 2C19.[6]

Protocols

In vitro. TMC 125 is dissolved in DMSO.[6]

References

[1] Etravirine: R165335, TMC 125, TMC-125, TMC125. Drugs R D. 2006, 7(6): 367-373.
[2] Mills AM, et al. Efficacy and safety of etravirine (TMC125) in patients with highly resistant HIV-1: primary 24-week analysis. AIDS. 2007, 21(6): F1-F10.
[3] Andries K, et al. TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1. Antimicrob Agents Chemother. 2004, 48(12): 4680-4686.
[4] Song I, et al. Effects of etravirine alone and with ritonavir-boosted protease inhibitors on the pharmacokinetics of dolutegravir. Antimicrob Agents Chemother. 2011, 55(7): 3517-3521.
[5] John J, et al. Effects of Etravirine on the Pharmacokinetics and Pharmacodynamics of Warfarin in Rats. Br J Pharmacol. 2012
[6] Yanakakis LJ, et al. Biotransformation of the antiretroviral drug etravirine: metabolite identification, reaction phenotyping, and characterization of autoinduction of cytochrome P450-dependent metabolism. Drug Metab Dispos. 2012, 40(4): 803-814.

Please click here to fill online order form, and we will make sure to supply you product with detail information. This process usually takes between 24 to 48 hours, depending on products stock avaliability. All inquires and subsequent projects are handled in the strictest confidence and will be backed by a confidentiality agreement if required.
KareBayTM provides scientists and clinicians with a wide range of biotechnological products and science lab supplies for chemical research and analyzing life processes. KareBay's extensive capabilities include commercializing reagents and kits, manufacturing biotech products and providing contract research services to organizations worldwide. Our many global labs, offices, and business partners enable KareBay to extend its products and services to its customer base around the world.

Our products are used for research, laboratory and further evaluation purposes. They are not for human use.